fda warning letters compounding semaglutide october 2025 Beyond the Headlines: to GLP-1 Compounders Compounded "semaglutide" is not FDA-approved

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

Sweetness for Everyone - If you're looking to manage your blood sugar levels while still satisfying your sweet tooth, our allulose sugar is your solution

Formulated to Support GLP-1 Pathways: GLP-1 is a natural hormone in the body associated with wellness

Keep calm and carrot on - health-conscious chain Smoothie King has launched a special menu for those who are on GLP-1 medications like Ozempic.

They discuss the underlying science, current research, and the challenges and implications of integrating these innovative treatments into addiction care

NASM is ensuring trainers are ready for this evolution with our evidence-based Understanding Weight Loss Medications Course: The industry is evolving